AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation

Recruitingn/aAges 18 Years - 45 YearsAllXijing Hospital of Digestive Diseases
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to identify the characteristics of brain functional connectivity in refractory constipation and fluoxetine-sensitive patients. The main questions it aims to answer are: * Investigating the alterations in brain functional connectivity in patients with refractory constipation and fluoxetine-sensitive patients * Assessing the predictive value of brain functional connectivity regarding the efficacy of fluoxetine and standard protocol treatments for constipation. Participants will receive: * Standard physiological and psychological assessments of constipation * BOLD-fMRI tests * Standard protocol and fluoxetine treatment If there is a comparison group: Researchers will compare: Refractory group/Fluoxetine sensitive group to see the specific brain alterations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * 18โ‰ค age โ‰ค 45 years old * Right-handed * Patients diagnosed as functional constipation according to the Rome IV criteria * Informed consent of patients Exclusion Criteria: * Complicated with gastrointestinal organic disease or significant functional abnormalities (tuberculosis, polyps, Crohn's disease, tumors, congenital megacolon, pelvic floor muscle relaxation, abnormal colonic transit test, etc.) * Long-term intense exercise (continuous exercise for more than 8 hours per week, such as marathon runners or triathletes) * No history of chronic pain, no recent major trauma * Drug abuse or tobacco dependence (half a pack or more per day) * Combined hypothyroidism and Parkinson's disease * Patients with confirmed mental illness or neurological disorders who take psychotropic drugs, analgesics or hormones * History of abdominal surgery (appendectomy, hysterectomy, or cholecystectomy) * Contraindications to functional magnetic resonance imaging (claustrophobia, metal implants) * Pregnant or lactating women with constipation after delivery * Patients with other benign and malignant tumors and autoimmune diseases * Infectious diseases such as hepatitis B, hepatitis C, AIDS, etc. * Heart disease, organ failure and other chronic diseases that require long-term medication or affect the quality of life
๐Ÿ’Š

What it tests

  • BOLD-fMRI
  • Regular treatment of functional constipation
  • fluoxetine
๐Ÿ“

Where

3 sites
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, China
Xi'an International Medical Center Hospital
Xi'an, China
Xijing Hospital, Fourth Military Medical University
Xi'an, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy